This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Cranial nerves
CD2_BENIGN_CRANIAL_NERVE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum nervi cranialis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Cranial nerves
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Cranial nerves
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1011 | 570 | 441 |
| Unadjusted period prevalence (%) | 0.19 | 0.19 | 0.19 |
| Median age at first event (years) | 56.65 | 55.49 | 58.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 896
- Matched controls
- 8958
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.30
ICD-10 Finland
Acoustic neuroma
+∞
323.0
744
*
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
78.8
243.5
271
49
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
+∞
236.2
216
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
75.0
168.8
190
32
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
19.0
138.0
220
151
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
11.8
124.9
249
283
DFF00
NOMESCO Finland
Pure tone audiometry
8.8
123.3
298
479
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
43.0
98.9
123
33
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
+∞
85.8
81
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
84.7
80
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
189.9
83.7
86
5
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
82.6
78
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
+∞
82.6
78
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
5.1
76.2
284
746
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.6
72.6
308
920
H02AB02
ATC
dexamethasone; systemic
30.5
71.4
96
35
DFF15
NOMESCO Finland
Speech audiometry
7.8
59.7
146
217
WF002
NOMESCO Finland
Radical radiotherapy
130.7
57.6
61
5
DFF59
NOMESCO Finland
Other assessment of balance
25.8
55.6
78
33
G51.0
ICD-10 Finland
Bell palsy
13.0
54.0
98
84
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
52.6
50
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
146.2
52.4
55
*
22510
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves (including optic)
+∞
49.4
47
*
AAE32
NOMESCO Finland
Translabyrinthine excision acoustic neurinome
+∞
47.3
45
*
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
242.0
45.4
46
*
115
Kela drug reimbursment
Breast cancer
+∞
45.2
43
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.8
45.1
109
157
N07CA01
ATC
betahistine; oral
5.1
43.4
148
333
130
Kela drug reimbursment
Malignant tumour
+∞
42.0
40
*
PJA12
NOMESCO Finland
Sentinel node biopsy
426.2
41.5
41
*
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
11.6
40.1
76
71
AAE34
NOMESCO Finland
Other operations on acoustical nerv
+∞
38.8
37
*
H02.2
ICD-10 Finland
Lagophthalmos
57.7
37.7
44
8
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
382.4
37.3
37
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
36.7
35
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.6
35.9
71
72
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
34.6
33
*
9560/0-C72.5
ICD-O-3
Schwannoma, NOS, of cranial nerve, NOS
+∞
34.6
33
*
Z3229
NOMESCO Finland
Other healthcare associate professional
4.1
33.7
142
391
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
77.2
33.1
37
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
121.2
32.9
35
*
2152
FHL
Extraction, big brain
+∞
32.5
31
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
117.6
31.9
34
*
116
Kela drug reimbursment
Prostate cancer
+∞
31.4
30
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
30.4
29
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
15.5
30.4
50
34
WF003
NOMESCO Finland
Adjuvant radiotherapy
301.2
28.9
29
*
WF099
NOMESCO Finland
Other radiotherapy
82.9
28.9
32
*
H93.1
ICD-10 Finland
Tinnitus
4.2
28.1
113
296
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
290.0
27.9
28
*
A04AA02
ATC
granisetron; systemic, transdermal
103.3
27.8
30
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
27.6
267
1299
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
278.9
26.9
27
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
26.5
193
794
UDC00
NOMESCO Finland
Ear microscopy
3.9
26.0
114
322
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
139.0
25.7
27
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
25.7
156
566
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.8
25.2
74
138
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.6
24.9
120
367
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
23.5
24.0
34
15
ZX050
NOMESCO Finland
Stereotactic radiotherapy
128.4
23.7
25
*
ZXC40
NOMESCO Finland
Use of ultrasound
31.0
22.9
30
10
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.3
22.3
70
141
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
22.0
21
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
17.1
21.1
33
20
AA1AD
NOMESCO Finland
CT of head and brain
2.2
20.9
257
1374
L02BA01
ATC
tamoxifen; oral
78.7
20.8
23
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
20.6
137
526
L02AE02
ATC
leuprorelin; implant, parenteral
33.4
20.3
26
8
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
20.3
362
2261
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
20.0
406
2657
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
107.4
19.6
21
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.4
19.6
99
313
HAB40
NOMESCO Finland
Wedge excision of mammary gland
25.2
19.6
27
11
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.2
19.2
43
55
R5120
NOMESCO Finland
Preparation of an aid
5.9
19.0
54
97
HAC20
NOMESCO Finland
Total mastectomy
102.2
18.6
20
*
R42
ICD-10 Finland
Dizziness and giddiness
2.1
18.2
237
1288
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
53.6
18.0
21
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
17.8
17
*
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
5.4
17.7
54
106
ZZC00
NOMESCO Finland
Graft of fascia
97.0
17.6
19
*
R4110
NOMESCO Finland
Physiotherapy
2.1
17.2
246
1388
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
16.7
16
*
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
16.7
16
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
16.7
16
*
L02BG04
ATC
letrozole; oral
11.9
16.6
30
26
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
91.8
16.6
18
*
Z31.5
ICD-10 Finland
Genetic counselling
5.3
15.7
48
95
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
15.7
15
*
L02BB03
ATC
bicalutamide; oral
+∞
15.7
15
*
L01BC06
ATC
capecitabine; oral
+∞
15.7
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
162.7
15.5
16
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
162.7
15.5
16
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
15.5
176
895
WX402
NOMESCO Finland
General anaesthesia
2.4
15.3
139
634
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
15.2
251
1487
C50.99
ICD-10 Finland
Breast, unspecified
+∞
14.6
14
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
14.6
14
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.6
14
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
152.3
14.5
15
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
14.4
313
2033
H91.9
ICD-10 Finland
Hearing loss, unspecified
3.8
14.2
60
164
8000/0-C72.4
ICD-O-3
Neoplasm, benign of acoustic nerve
+∞
13.6
13
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
34.6
13.5
17
5
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
142.0
13.5
14
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
142.0
13.5
14
*
CBH30
NOMESCO Finland
Tarsorraphy
142.0
13.5
14
*
CBH25
NOMESCO Finland
Tarsorrhaphy
142.0
13.5
14
*
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
4.6
13.2
45
101
WX110
NOMESCO Finland
Local anesthesy
1.7
13.1
573
4561
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
7.1
12.9
31
45
Z3226
NOMESCO Finland
Physiotherapist
2.1
12.9
168
902
A04AA01
ATC
ondansetron; systemic, rectal
5.5
12.8
37
69
NK6AN
NOMESCO Finland
Total body bone isotope imaging
32.5
12.6
16
5
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
12.5
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
12.5
12
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
12.5
12
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
+∞
12.5
12
*
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
131.7
12.5
13
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.3
12.4
32
52
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
3.2
12.4
65
213
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.8
12.3
34
60
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
12.3
122
576
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.9
12.3
30
45
ZXA05
NOMESCO Finland
Left side
1.8
12.0
230
1416
HA1AA
NOMESCO Finland
X-ray mammography
4.3
12.0
44
107
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
47.3
11.9
14
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.5
11.7
34
64
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
16.7
11.7
18
11
QAJ10
NOMESCO Finland
Browlift
16.7
11.7
18
11
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.0
11.7
28
41
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
65.8
11.6
13
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
11.6
211
1275
JN4BD
NOMESCO Finland
Extensive body CT
3.2
11.6
60
195
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
11.5
11
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
11.5
11
*
3252
FHL
Repair with foreign material (spring, magnet)
+∞
11.5
11
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
11.5
11
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
11.5
11
*
L03AA13
ATC
pegfilgrastim; parenteral
121.5
11.4
12
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
121.5
11.4
12
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
17.3
11.2
17
10
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
43.9
10.9
13
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.0
10.5
28
48
Y77
ICPC
Malignant neoplasm prostate
111.2
10.4
11
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
111.2
10.4
11
*
CBW99
NOMESCO Finland
Other operation on eyelid
+∞
10.4
10
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
10.4
10
*
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
19.0
10.3
15
8
G91.1
ICD-10 Finland
Obstructive hydrocephalus
11.4
10.1
18
16
AAH50
NOMESCO Finland
Cranial nerve anastomosis
55.6
9.7
11
*
DAX08
NOMESCO Finland
Fitting of hearing aid
2.8
9.7
60
220
ZXA00
NOMESCO Finland
Right side
1.7
9.6
233
1531
H02
ICPC
Hearing complaint
2.0
9.6
123
649
H02.1
ICD-10 Finland
Ectropion of eyelid
10.2
9.5
18
18
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
9.4
103
508
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
101.0
9.4
10
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
17.7
9.4
14
8
ZZF00
NOMESCO Finland
Graft of adipose tissue
17.7
9.4
14
8
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
+∞
9.4
9
*
ZZK00
NOMESCO Finland
Graft of nerve
+∞
9.4
9
*
X76
ICPC
Malignant neoplasm breast female
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.9
9.3
56
203
N03AF01
ATC
carbamazepine; oral, rectal
2.8
9.1
58
217
D32.05
ICD-10 Finland
Cerebral meninges
37.1
9.0
11
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
37.1
9.0
11
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
37.1
9.0
11
*
ZXE00
NOMESCO Finland
One hour or less
1.6
8.9
313
2263
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
24.3
8.9
12
5
H47.1
ICD-10 Finland
Papilloedema, unspecified
12.7
8.9
15
12
N03AF02
ATC
oxcarbazepine; oral
3.8
8.8
36
98
S18
ICPC
Laceration/cut
1.6
8.8
349
2601
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.7
731
6496
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
50.5
8.7
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
8.3
8
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
8.3
8
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.0
8.3
32
83
JN4CD
NOMESCO Finland
Very extensive body CT
4.6
8.2
27
60
SPAT1153
SPAT
Removal of sutures
1.6
8.2
273
1943
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
8.2
8.1
17
21
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
6.9
8.1
19
28
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
22.2
8.0
11
5
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
22.2
8.0
11
5
TAB00
NOMESCO Finland
Lumbar puncture
2.9
7.9
46
163
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
10.9
7.8
14
13
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
45.4
7.7
9
*
H81.0
ICD-10 Finland
Ménière disease
3.7
7.7
32
89
KCD02
NOMESCO Finland
Transurethral resection of bladder
18.5
7.6
11
6
CBF99
NOMESCO Finland
Other operation for ectropion
25.2
7.6
10
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
25.2
7.6
10
*
ZXC96
NOMESCO Finland
Robot assisted procedure
8.9
7.6
15
17
XCK00
NOMESCO Finland
Perimetry
2.3
7.5
67
303
G50.1
ICD-10 Finland
Atypical facial pain
4.9
7.5
23
48
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
5.1
7.4
22
44
N76
ICPC
Neoplasm nervous system unspecified
80.7
7.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
80.7
7.4
8
*
DC1AD
NOMESCO Finland
Temporalbone CT
6.0
7.4
19
32
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.7
7.4
20
36
3259
FHL
Other measure in this category
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
2151
FHL
Resection, big brain
+∞
7.3
7
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
7.3
7
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
7.3
7
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
7.3
7
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
7.3
7
*
2159
FHL
Other measure in this category
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
A02BC02
ATC
pantoprazole; systemic
1.5
7.3
532
4466
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.8
7.3
44
162
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
15.9
7.2
11
7
L03AA02
ATC
filgrastim; parenteral
30.3
7.2
9
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
20.2
7.1
10
5
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
20.2
7.1
10
5
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.3
7.0
33
102
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.9
7.0
27
71
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
6.8
6.8
16
24
RK520
NOMESCO Finland
NA
11.0
6.8
12
11
R51.80
ICD-10 Finland
Headache
1.8
6.8
119
704
CBK10
NOMESCO Finland
Operation for lagophtalmus
40.3
6.8
8
*
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
40.3
6.8
8
*
A79
ICPC
Malignancy NOS
40.3
6.8
8
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
16.8
6.8
10
6
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
4.8
6.7
21
45
Z3231
NOMESCO Finland
Registered nurse
1.6
6.7
211
1471
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
6.5
136
848
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
70.3
6.4
7
*
QAJ20
NOMESCO Finland
Subperiosteal facelift
70.3
6.4
7
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
70.3
6.4
7
*
R4135
NOMESCO Finland
Rehabilitation for hearing problems
4.1
6.4
23
57
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
6.0
6.3
16
27
D43.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cranial nerves
+∞
6.3
6
*
D33
ICD-10 Finland
Benign neoplasm of brain and other parts of central nervous system
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
9560/0-C71.9
ICD-O-3
Schwannoma, NOS, of brain, NOS
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
3253
FHL
Tarsoraphy
+∞
6.3
6
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
26.9
6.2
8
*
RK320
NOMESCO Finland
NA
7.1
6.2
14
20
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.9
6.2
92
516
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.3
6.1
21
50
RK110
NOMESCO Finland
NA
7.7
6.1
13
17
Z51.5
ICD-10 Finland
Palliative care
3.6
6.1
25
70
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
12.6
6.1
10
8
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
6.0
49
213
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
132
226
6.57
75.62
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
58
41
14.95
64.32
1.8
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
397
2231
2.28
33.70
2.0
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
432
2592
2.16
30.43
2.2
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
528
3564
2.01
25.69
6.3
5.1
mmol/l
1.2
1.2
0.34
488
3151
(3033658) Prothrombin time (PT) actual/Normal
326
1885
2.08
24.11
3.7
3.4
%
93.0
88.7
2.43
321
1830
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
300
1735
2.04
21.81
1.9
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
553
3943
1.89
21.37
7.0
5.6
mmol/l
1.2
1.2
0.29
485
3342
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
494
3463
1.83
19.51
3.6
3.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
520
3825
1.74
16.41
5.8
3.8
umol/l
12.2
12.0
0.10
499
3582
(3013826) Glucose [Moles/volume] in Serum or Plasma
618
4775
1.76
16.34
5.1
4.2
mmol/l
6.6
6.8
1.96
596
4442
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
104
434
2.56
16.32
3.9
1.5
ug/l
15.0
3.6
0.66
84
333
(3003396) Base excess in Arterial blood by calculation
167
899
2.03
14.20
7.2
6.5
mmol/l
0.8
1.3
0.68
120
704
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
166
902
2.01
13.73
7.2
6.5
kpa
5.1
5.1
0.05
157
869
(3027801) Oxygen [Partial pressure] in Arterial blood
166
902
2.01
13.73
7.2
6.5
kpa
15.9
11.7
11.98
156
868
(3002256) Pathology report gross observation
123
609
2.16
13.01
1.3
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
725
6129
1.65
11.22
7.6
5.4
u/l
78.1
75.6
0.67
684
5674
(3013650) Neutrophils [#/volume] in Blood by Automated count
548
4377
1.55
10.46
8.5
6.6
e9/l
4.2
4.2
0.16
461
3794
(3024561) Albumin [Mass/volume] in Serum or Plasma
436
3328
1.55
10.11
4.2
3.7
g/l
35.8
35.8
0.07
403
3066
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
904
8205
1.96
9.98
15.1
12.4
mg/l
24.9
22.8
0.94
735
6336
(3032080) INR in Blood by Coagulation assay
423
3217
1.54
9.92
5.7
9.8
inr
1.1
1.3
4.46
112
922
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
110
591
1.97
9.28
2.4
2.4
au/ml
28.4
21.2
—
8
22
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
101
528
2.01
9.21
1.3
1.3
au/ml
19.0
44.5
—
5
23
(42870588) Differential panel, method unspecified - Blood
349
2598
1.52
8.77
6.2
5.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
50
198
2.60
8.76
1.9
1.3
e6/l
2161.9
729.9
0.33
42
164
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
50
198
2.60
8.76
1.7
1.2
e6/l
83.2
49.5
0.19
39
158
(3044290) Cell count panel - Cerebral spinal fluid
45
170
2.72
8.65
1.7
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
936
8673
2.07
8.60
18.3
14.8
mmol/l
139.9
139.8
0.73
920
8438
(40758558) Short blood count panel - Blood
259
1836
1.55
8.02
5.9
4.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
27
79
3.48
7.99
2.2
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
654
5588
1.48
7.97
4.4
4.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
340
2559
1.50
7.94
3.4
2.0
mmol/l
2.4
2.4
0.16
280
2135
(3023103) Potassium [Moles/volume] in Serum or Plasma
935
8703
1.99
7.82
18.5
14.9
mmol/l
4.0
4.0
2.79
918
8450
(3012095) Magnesium [Moles/volume] in Serum or Plasma
177
1175
1.61
7.20
3.2
2.6
mmol/l
0.8
0.8
0.35
166
1091
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
38
4.53
7.19
2.2
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
440
3534
1.43
7.14
6.2
5.7
%
0.7
0.7
0.84
403
3274
(3002030) Lymphocytes/100 leukocytes in Blood
460
3734
1.43
6.99
6.3
5.8
%
27.8
28.0
0.16
420
3459
(3018418) pH of Serum or Plasma
304
2288
1.47
6.92
4.4
3.2
ph
7.4
7.4
0.03
49
381
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
859
7868
1.61
6.76
15.0
11.2
ml/min/173m2
79.7
78.8
0.63
727
6333
(3006504) Eosinophils/100 leukocytes in Blood
448
3643
1.41
6.63
6.2
5.7
%
2.8
3.0
1.02
408
3370
(3018010) Neutrophils/100 leukocytes in Blood
454
3706
1.41
6.55
6.0
5.6
%
57.5
57.2
0.25
419
3446
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
80
3.18
6.47
2.0
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
448
3655
1.41
6.45
6.5
6.0
%
8.8
8.6
0.47
412
3399
(3020779) Urea [Moles/volume] in Serum or Plasma
107
656
1.71
5.90
4.4
6.6
mmol/l
9.1
9.7
0.42
101
623
(3006315) Basophils [#/volume] in Blood
474
3952
1.38
5.79
6.0
5.6
e9/l
0.0
0.0
0.31
391
3416
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
202
1450
1.49
5.71
3.0
2.1
mmol/l
2.5
2.4
0.94
171
1250
(3019198) Lymphocytes [#/volume] in Blood
481
4030
1.37
5.65
6.0
5.6
e9/l
1.8
1.9
0.62
404
3537
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
116
738
1.65
5.56
4.3
2.9
u/l
242.0
236.5
0.14
105
691
(3001604) Monocytes [#/volume] in Blood
470
3933
1.36
5.52
6.0
5.5
e9/l
0.6
0.6
0.06
388
3394
(3013115) Eosinophils [#/volume] in Blood
485
4090
1.36
5.37
6.3
5.7
e9/l
0.2
0.2
0.56
404
3591
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
422
3489
1.36
5.28
2.4
2.3
nmol/l
78.9
78.1
0.27
373
3072
(3003458) Phosphate [Moles/volume] in Serum or Plasma
150
1032
1.53
5.17
4.6
5.0
mmol/l
1.0
1.0
0.41
140
943
(3023410) Appearance of Cerebral spinal fluid
24
86
2.83
5.17
2.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
938
8900
1.75
5.07
11.1
9.0
u/l
25.8
25.7
0.10
911
8540
(3013707) Erythrocyte sedimentation rate by Westergren method
696
6235
1.37
5.07
4.0
4.2
mm/h
11.4
11.7
0.19
637
5735
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
9
10.08
5.03
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
272
2110
1.40
5.00
3.3
3.0
e6/l
0.4
0.4
0.03
201
1584
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
206
1522
1.44
4.98
3.4
2.7
ug/l
0.7
0.7
0.11
139
997
(3031040) Bacteria [#/volume] in Urine by Automated count
599
5251
1.35
4.98
4.8
4.4
e6/l
711.2
2113.8
—
10
71
(3002582) Erythrocytes [#/volume] in Urine
293
2309
1.38
4.89
3.3
3.1
e6/l
61.0
97.5
0.49
224
1766
(40768793) Breast Pathology biopsy report
19
62
3.10
4.81
1.4
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
307
2458
1.36
4.59
3.4
2.7
u/l
36.3
32.1
0.44
291
2334
(3026008) Bacteria identified in Urine by Culture
305
2440
1.36
4.58
2.8
3.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
119
805
1.54
4.43
1.4
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
112
2.45
4.41
1.1
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
6
11.74
4.28
2.4
1.0
u/ml
30.5
14.2
—
7
6
(36304419) Bacteria [Presence] in Urine
261
2057
1.36
4.28
3.2
2.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
165
1209
1.44
4.14
2.9
2.7
e6/l
2.4
2.5
0.12
86
644
(3026782) Osmolality of Urine
198
1499
1.40
4.13
2.9
2.6
mosm/kgh2o
562.8
547.9
0.33
163
1268
(3018095) Leukocytes [#/volume] in Urine
332
2730
1.32
4.06
3.8
3.5
e6/l
140.3
99.5
0.16
242
1910
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
592
5264
1.30
4.03
3.2
3.0
u/l
47.4
46.8
0.07
554
4870
(3007461) Platelets [#/volume] in Blood
961
9247
1.79
4.03
23.0
18.4
e9/l
249.6
249.3
0.03
939
8983
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
176
1314
1.41
3.98
2.8
2.6
e6/l
1.3
1.2
0.11
94
746
(3024731) MCV [Entitic volume]
961
9251
1.78
3.96
23.0
18.4
fl
90.7
91.2
2.92
952
9092
(3026361) Erythrocytes [#/volume] in Blood
961
9253
1.78
3.93
23.1
18.4
e12/l
4.5
4.5
0.14
941
8954
(3000963) Hemoglobin [Mass/volume] in Blood
961
9256
1.77
3.88
23.1
18.5
g/l
134.7
136.2
2.62
954
9095
(3009214) Lutropin [Units/volume] in Serum or Plasma
32
153
2.13
3.82
1.6
1.3
u/l
13.3
9.8
0.39
20
129
(40768800) Prostate Pathology biopsy report
14
44
3.21
3.78
1.1
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
960
9252
1.75
3.75
23.0
18.3
pg
30.2
30.4
2.67
951
9092
(3010813) Leukocytes [#/volume] in Blood
960
9254
1.74
3.72
23.1
18.4
e9/l
6.7
6.7
0.07
939
8960
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
65
399
1.67
3.64
11.1
9.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
76
487
1.61
3.60
2.3
2.3
nmol/l
11.9
14.9
2.27
65
429
(3000991) Gas panel - Venous blood
93
625
1.54
3.59
9.1
7.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
908
8654
1.48
3.55
14.2
12.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
827
7759
1.36
3.52
4.9
4.8
mu/l
1.9
2.1
0.81
748
7064
(3023368) Bacteria identified in Blood by Culture
247
1983
1.32
3.51
4.1
4.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
123
882
1.45
3.47
1.7
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
542
4818
1.27
3.46
2.7
2.7
—
—
—
0
0
(3019225) pH of Specimen
113
805
1.45
3.30
4.7
3.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
73
476
1.58
3.23
1.5
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
53
319
1.70
3.21
1.2
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
320
2687
1.28
3.21
2.3
2.2
u/l
179.2
230.2
0.81
306
2520
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
195
1.88
3.10
1.5
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
407
3534
1.25
3.05
10.2
8.3
e9/l
0.0
0.0
0.48
318
2901
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
132
982
1.40
3.05
2.2
2.6
%
23.9
23.3
0.11
110
834
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
301
1.70
3.04
1.3
1.7
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
5
5
10.04
2.98
2.6
2.0
pmol/l
58.4
60.0
—
5
5
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
5
10.04
2.98
2.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
52
2.72
2.89
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
319
2707
1.26
2.89
5.7
3.8
ug/l
3.4
1.9
0.83
284
2425
(3049717) Cytology report of Urine Cyto stain
42
246
1.74
2.83
2.3
1.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
36
3.08
2.81
1.1
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
85
593
1.47
2.79
2.2
2.0
g/l
0.2
0.2
1.25
79
539
(3052851) Hemolysis interference index of Serum or Plasma
40
233
1.75
2.76
2.9
3.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
294
2483
1.26
2.75
2.5
2.3
u/l
62.9
57.9
0.40
271
2274
(3025549) Creatine [Moles/time] in 24 hour Urine
5
6
8.37
2.75
2.0
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
199
1601
1.30
2.75
2.7
2.4
e6/l
5.0
6.2
0.71
171
1400
(3004789) Transferrin [Mass/volume] in Serum or Plasma
141
1081
1.35
2.72
2.1
2.4
g/l
2.3
2.3
0.10
125
1004
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
410
3598
1.23
2.71
2.1
2.0
pmol/l
95.2
95.8
0.09
220
1801
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
262
2188
1.27
2.69
4.8
3.7
%
22.6
23.7
0.59
139
1018
(3036489) Thrombin time
43
258
1.70
2.68
2.4
1.9
s
22.1
21.4
0.39
37
228
(3000494) Fungus identified in Specimen by Culture
124
937
1.37
2.62
1.4
1.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
14
55
2.57
2.62
1.7
1.8
nmol/l
19.1
19.0
0.02
14
48
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
7
7.17
2.55
4.8
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
160
1263
1.32
2.53
1.6
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
139
1076
1.34
2.52
1.9
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
46
287
1.63
2.49
1.3
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
94
686
1.41
2.45
2.7
2.3
u/l
32.4
42.2
0.59
82
572
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
57
2.48
2.45
2.6
4.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
237
1988
1.25
2.32
1.3
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
53
350
1.54
2.29
2.5
2.0
u/l
36.6
39.7
0.48
46
309
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
23
3.50
2.27
1.5
2.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
37
225
1.67
2.24
4.2
1.4
mg/l
51.5
42.8
0.28
29
185
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
37
225
1.67
2.24
4.3
1.4
mg/l
36.1
56.2
0.33
29
185
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
9
5.58
2.21
1.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
14
4.30
2.15
1.5
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
14
4.30
2.15
1.3
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
721
6796
1.21
2.05
19.2
14.9
%
13.7
13.6
0.27
711
6621
(3022948) Iron [Moles/volume] in Serum or Plasma
148
1191
1.28
2.05
2.1
2.4
umol/l
12.8
13.4
0.29
132
1094
(3024869) Neuronal Ab [Presence] in Serum
6
15
4.02
2.04
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
76
2.12
2.03
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
638
5950
1.20
2.02
3.6
3.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
16
77
2.10
1.97
2.4
3.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
17
85
2.02
1.91
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
686
6456
1.19
1.90
4.1
4.0
pmol/l
14.9
14.9
0.04
618
5862
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
115
1.84
1.84
1.4
1.4
pmol/l
249.6
337.7
1.15
16
84
(3009542) Hematocrit [Volume Fraction] of Blood
783
7478
1.21
1.76
17.7
13.7
%
40.1
39.9
0.27
573
5141
(3021960) Folate [Moles/volume] in Serum or Plasma
239
2064
1.21
1.75
1.5
1.5
nmol/l
21.4
21.2
0.06
190
1735
(3005719) IgG [Mass/volume] in Serum or Plasma
70
519
1.37
1.73
3.7
2.3
g/l
11.0
10.9
0.05
63
473
(40768797) Stomach Pathology biopsy report
141
1154
1.26
1.72
1.1
1.2
—
—
—
0
0
(3013512) EKG study
283
2493
1.19
1.66
4.4
3.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
234
2027
1.20
1.66
2.2
2.2
mg/l
3.0
2.9
0.12
198
1709
(4010399)
46
650
0.69
1.65
1.2
1.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
7
25
2.81
1.65
2.0
1.7
e9/l
0.2
0.2
—
7
25
(3012441) Differential panel - Pleural fluid
12
56
2.16
1.61
1.5
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
20
3.01
1.58
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
69
524
1.34
1.49
3.5
3.7
kpa
5.0
5.2
2.05
60
490
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
129
0.38
1.49
1.4
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
733
6998
1.17
1.48
19.5
16.5
g/l
332.2
332.5
0.35
728
6945
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
102
820
1.27
1.46
2.6
2.3
umol/l
7.2
7.1
0.02
94
707
(4281824)
9
39
2.32
1.43
1.4
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
40
281
1.44
1.38
1.9
1.8
ug/l
2.3
1.8
0.17
34
247
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
16
89
1.81
1.37
1.0
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
9
41
2.21
1.37
3.1
3.0
umol/l
27.7
30.9
—
9
27
(3047181) Lactate [Moles/volume] in Blood
37
257
1.46
1.35
5.5
6.0
mmol/l
1.3
1.3
0.14
31
232
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
105
1.73
1.33
1.7
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
68
1.92
1.33
1.6
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
67
517
1.32
1.32
3.6
3.7
ph
7.4
7.4
—
9
59
(1616796) Gas panel - Central venous blood
23
145
1.60
1.30
4.5
3.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
253
0.59
1.25
1.3
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
21
131
1.62
1.24
4.0
2.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
45
2.01
1.23
3.7
2.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
55
419
1.33
1.20
3.7
1.4
g/l
2.1
1.2
0.80
47
384
(4306422)
17
101
1.69
1.20
1.4
1.3
—
—
—
0
0
(4024509)
13
71
1.84
1.19
1.8
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
125
1.61
1.18
1.5
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
433
4025
1.13
1.17
3.8
3.7
estimate
0.0
0.0
0.50
77
670
(3045142) Bone marrow Pathology biopsy report
11
57
1.94
1.17
1.4
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
20
2.51
1.15
1.2
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
428
3981
1.13
1.14
5.2
4.9
estimate
0.0
0.0
0.50
76
693
(4094501)
35
251
1.41
1.12
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
51
1.97
1.11
1.7
1.5
—
—
—
0
0
(4268621)
13
73
1.79
1.11
2.8
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
58
452
1.30
1.10
1.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
41
1.96
1.09
1.0
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
63
498
1.28
1.08
3.6
3.7
mmol/l
0.8
1.8
2.55
49
371
(3006184) Hemoglobin [Mass/volume] in Capillary blood
25
169
1.49
1.08
2.1
2.1
g/l
130.5
131.2
0.04
17
125
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
89
1.70
1.08
1.7
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
236
1.41
1.08
1.5
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
161
1.50
1.07
5.7
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
56
437
1.30
1.06
2.4
2.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
113
1.60
1.06
1.3
1.2
u/ml
1.8
2.3
—
8
36
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
7
33
2.13
1.05
1.3
2.4
nmol/l
1.0
7.9
—
7
25
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
64
509
1.27
1.05
1.4
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
90
1.68
1.04
1.5
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
353
3261
1.13
1.04
3.5
3.7
ng/l
40.1
65.6
0.52
247
2283
(3043410) Blood group antigens tested for on Red Blood Cells
5
22
2.28
1.03
1.6
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
46
351
1.33
1.03
1.5
1.8
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
9
47
1.92
1.02
1.8
6.9
—
76.5
—
0
15
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
53
1.90
1.01
1.1
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
22
147
1.51
1.01
1.6
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
83
686
1.23
0.99
2.7
2.2
ml/min/173m2
60.6
66.9
0.83
34
279
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
44
336
1.32
0.98
3.7
4.1
mmol/l
24.4
24.8
0.53
39
314
(3021387) Prolactin [Units/volume] in Serum or Plasma
28
198
1.43
0.98
2.0
1.6
mu/l
299.5
273.8
0.27
28
176
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
423
3961
1.12
0.98
3.8
3.6
estimate
0.0
0.0
0.00
71
688
(3041096) Erythrocytes [Presence] in Urine by Automated
233
2105
1.14
0.97
3.7
3.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
36
1.95
0.97
1.4
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
36
1.95
0.97
1.4
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
108
1.58
0.97
1.8
1.3
nmol/l
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
216
1.40
0.96
2.7
2.7
u/ml
0.3
0.4
0.35
20
128
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
128
1107
1.18
0.96
5.0
4.8
%
32.3
32.6
0.13
77
725
(3037522) Nuclear Ab [Titer] in Serum
130
1126
1.18
0.96
1.3
1.3
titre
780.8
553.5
0.49
25
265
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
56
445
1.27
0.95
2.5
3.1
pmol/l
4.6
4.5
0.08
51
383
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
51
1.77
0.94
1.8
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
28
2.15
0.91
1.5
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
110
1.55
0.91
1.4
1.2
u/ml
1.6
5.8
—
9
51
(21494434) Karyotype in Bone marrow
11
63
1.75
0.90
1.0
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
35
263
1.34
0.89
4.4
1.3
g/l
1.0
0.3
0.65
26
231
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
87
1.62
0.88
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
161
1.44
0.87
1.6
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
860
8411
1.15
0.86
4.6
4.6
mmol/l
1.5
1.5
0.51
779
7719
(3027945) Reticulocytes/100 erythrocytes in Blood
104
894
1.18
0.85
2.3
2.2
%
1.8
1.8
0.03
92
788
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
57
1.76
0.84
1.7
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
47
1.71
0.80
1.5
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
66
548
1.22
0.79
5.2
4.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
107
929
1.17
0.79
2.1
2.3
ug/g
152.3
140.6
0.12
81
735
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
24
0.00
0.79
0.0
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
24
0.00
0.79
0.0
1.6
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
24
0.00
0.79
0.0
1.3
—
1.2
—
0
24
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
33
1.82
0.79
3.3
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
106
1.52
0.79
1.3
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
27
0.00
0.77
0.0
1.1
—
264.2
—
0
17
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
140
1.44
0.77
1.6
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
365
3428
1.10
0.77
2.8
2.7
ug/l
126.9
121.1
0.11
333
3134
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
865
8480
1.14
0.75
4.6
4.7
mmol/l
4.7
4.6
0.98
792
7821
(3035637) Corticotropin [Mass/volume] in Plasma
12
75
1.61
0.75
1.3
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
167
1.39
0.74
1.3
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
211
1.34
0.72
1.3
1.5
ug/g
298.1
316.0
0.20
17
125
(3036481) Cortisol [Moles/volume] in Serum or Plasma
86
740
1.18
0.72
2.9
1.8
nmol/l
361.2
361.0
0.00
78
677
(3034770) Mitochondria Ab [Titer] in Serum
29
220
1.33
0.72
1.1
1.2
—
915.0
—
0
6
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
40
318
1.27
0.71
1.6
1.7
g/l
1.7
1.5
0.85
34
277
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
57
1.58
0.71
1.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
48
392
1.24
0.69
3.6
3.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
42
1.67
0.68
1.3
1.5
ug/l
6.7
9.9
—
7
35
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
59
1.53
0.68
1.6
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
896
1.15
0.67
1.6
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
78
1.54
0.65
3.3
1.7
u/ml
7.6
54.6
0.44
12
73
(40767503) Oxygen content in Capillary blood by calculation
21
154
1.37
0.65
2.4
2.3
%
15.8
16.3
0.17
12
74
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
62
1.62
0.65
3.0
2.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
102
900
1.15
0.64
1.6
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
29
225
1.30
0.63
1.6
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
21
155
1.36
0.63
2.7
1.8
—
—
—
0
0
(4027681)
8
49
1.64
0.62
1.3
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
130
1.39
0.61
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
289
0.76
0.61
1.7
2.1
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
0.8
—
0
14
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
90
791
1.15
0.60
3.4
3.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
148
1.36
0.60
1.6
1.5
—
—
—
0
0
(3010421) pH of Blood
25
192
1.31
0.59
5.1
4.0
ph
7.4
7.4
0.43
20
155
(3007164) IgA [Mass/volume] in Serum or Plasma
165
1509
1.11
0.59
1.8
1.3
g/l
2.3
2.6
1.07
96
875
(3015235) Bicarbonate [Moles/volume] in Capillary blood
26
201
1.30
0.59
3.2
3.1
mmol/l
22.9
25.2
2.36
19
180
(37021550) Renin [Units/volume] in Plasma --upright
0
23
0.00
0.58
0.0
1.1
—
92.3
—
0
16
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
18
132
1.37
0.57
2.8
2.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
36
1.67
0.56
1.0
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
31
248
1.26
0.55
3.1
1.3
g/l
37.8
37.9
0.05
24
212
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
65
1.54
0.55
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.54
0.55
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
65
1.54
0.55
1.1
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
37
1.63
0.55
1.7
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
27
213
1.27
0.54
1.5
1.7
e6/l
11157.3
11169.2
0.00
22
163
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
99
1.42
0.54
1.1
1.0
u/ml
2.7
3.0
—
6
43
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
151
1.33
0.54
1.9
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
876
8631
1.11
0.53
5.2
5.2
mmol/l
2.8
2.7
0.99
796
7929
(3025130) Human papilloma virus identified in Specimen
11
74
1.49
0.53
1.5
1.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
24
187
1.29
0.53
5.5
3.2
mg/l
1.6
1.5
0.08
19
167
(3051651) Icteric interference index of Serum or Plasma
6
39
1.54
0.53
1.8
4.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
282
0.78
0.52
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
42
500
0.83
0.52
1.7
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
66
1.52
0.52
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
197
1.28
0.51
1.4
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
25
197
1.28
0.51
1.3
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
27
215
1.26
0.51
5.0
4.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
80
708
1.14
0.51
1.7
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
71
623
1.15
0.51
3.5
1.6
g/l
65.4
67.2
0.85
58
564
(3003434) Protein [Mass/volume] in Pleural fluid
11
75
1.47
0.51
1.5
1.3
g/l
31.7
28.2
0.56
11
66
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
65
1.39
0.50
1.3
1.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
27
335
0.80
0.50
1.1
1.3
u/ml
0.2
0.6
—
7
26
(4211845)
6
41
1.47
0.50
3.8
3.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
198
1.27
0.50
1.3
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
107
0.65
0.49
1.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
94
844
1.13
0.48
1.6
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
25
199
1.26
0.48
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
199
1.26
0.48
1.3
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
76
1.45
0.48
1.0
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
802
0.88
0.48
2.7
2.5
ug/l
6.2
7.8
0.78
60
709
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
177
1646
1.09
0.47
3.7
3.9
ng/l
122.7
422.4
3.05
145
1293
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
26
321
0.80
0.47
1.4
1.7
mg/l
1.2
2.8
2.29
19
225
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
55
477
1.16
0.46
1.3
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
32
264
1.22
0.46
2.6
2.9
g/l
0.4
0.3
0.15
13
86
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
31
255
1.22
0.46
1.7
1.6
iu/ml
0.0
0.1
—
5
50
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
827
8141
1.09
0.46
4.1
4.1
mmol/l
1.3
1.3
0.54
735
7398
(3024263) Appearance of Synovial fluid
7
49
1.43
0.46
1.4
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
178
1659
1.09
0.45
1.7
1.7
nmol/l
1098.3
1176.2
0.56
132
1243
(3012501) Base excess in Blood by calculation
20
156
1.29
0.45
5.9
4.2
mmol/l
2.7
2.8
0.03
15
100
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
175
0.74
0.45
1.3
1.5
—
—
—
0
0
(4146454)
15
112
1.34
0.44
3.5
2.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
112
1.34
0.44
2.2
2.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
247
1.22
0.44
1.1
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
74
659
1.13
0.44
3.2
2.3
e9/l
70.6
69.6
0.10
56
515
(3004588) Protein electrophoresis panel - Serum or Plasma
61
536
1.15
0.44
3.4
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
24
193
1.25
0.43
4.1
2.8
mmol/l
1.5
1.6
0.10
24
186
(3016879) Cocaine [Presence] in Urine
23
184
1.26
0.43
1.3
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
23
184
1.26
0.43
4.2
2.9
mmol/l
7.8
7.5
0.16
23
178
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
133
1439
0.91
0.43
1.3
1.3
u/ml
33.7
13.5
0.32
49
547
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
33
392
0.84
0.42
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
49
425
1.16
0.42
3.7
3.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
124
1143
1.10
0.41
1.2
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
2.0
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
2.0
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
64
568
1.14
0.41
3.8
4.1
%
0.1
0.0
0.09
16
108
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
27.0
—
0
16
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
15.9
—
0
16
(3025577) Chromium [Mass/volume] in Blood
8
59
1.36
0.41
1.9
2.0
ug/l
2.6
1.9
—
8
51
(3013293) Extractable nuclear Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
367
0.84
0.39
2.0
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
35
1.43
0.39
2.6
4.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
247
0.81
0.38
2.8
3.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
197
1.22
0.38
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
68
1.33
0.37
3.0
2.2
—
—
—
0
0
(3020891) Body temperature
40
346
1.16
0.37
4.8
4.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
259
2710
0.94
0.36
3.1
3.2
mg/l
35.1
183.9
1.99
150
1692
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
90
1.34
0.36
1.3
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
179
0.78
0.35
3.1
3.5
mg/l
13.7
26.3
—
7
114
(3041354) Potassium [Moles/volume] in Venous blood
15
117
1.29
0.35
2.2
2.3
mmol/l
3.9
4.1
1.33
15
117
(3035285) Chloride [Moles/volume] in Venous blood
15
117
1.29
0.35
2.2
2.3
mmol/l
106.7
105.5
0.52
15
117
(3004616) Nuclear Ab [Presence] in Serum
15
117
1.29
0.35
1.9
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
292
1.17
0.35
3.0
1.3
g/l
9.7
10.6
0.58
27
248
(3027456) Digoxin [Moles/volume] in Serum or Plasma
13
167
0.78
0.34
3.2
3.4
nmol/l
0.7
0.8
—
7
132
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
91
1.32
0.34
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
91
1.32
0.34
1.3
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
45
1.34
0.33
1.0
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
67
739
0.90
0.33
2.9
3.0
ng/l
126.7
206.1
1.68
59
681
(3026493) Urate [Moles/volume] in Serum or Plasma
227
2164
1.06
0.33
2.4
2.4
umol/l
352.7
6137.7
7.00
195
1852
(40761536) Microorganisms panel - Urine sediment
68
616
1.11
0.33
5.0
3.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
284
1.17
0.33
1.5
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
285
2965
0.95
0.33
3.0
3.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
61
550
1.12
0.32
3.3
3.1
e9/l
4.3
4.2
0.10
40
415
(3002179) Metamyelocytes/100 leukocytes in Blood
61
550
1.12
0.32
3.5
4.0
%
0.5
0.4
0.12
14
93
(3044941) Cell count panel - Synovial fluid
18
146
1.24
0.32
1.4
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
183
1.21
0.32
1.6
2.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
52
1.35
0.31
2.0
2.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
805
7951
1.06
0.31
6.0
6.1
mmol/mol
39.3
40.2
1.90
728
7367
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
53
1.32
0.31
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
129
1.24
0.30
1.8
2.2
u/l
3866.7
2377.9
—
8
57
(3017181) Myelocytes/100 leukocytes in Blood
65
592
1.10
0.30
3.9
4.1
%
0.6
0.8
0.22
16
121
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
93
1.29
0.30
1.3
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
93
1.29
0.30
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
93
1.29
0.30
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
318
3073
1.05
0.29
4.1
3.8
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
56
1.25
0.29
2.4
1.6
—
1.1
—
0
5
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
130
1.23
0.29
1.9
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
204
1.18
0.29
1.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
167
1.20
0.28
1.2
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
62
1.29
0.28
1.8
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
63
1.27
0.27
1.6
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
64
1.25
0.27
1.4
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
120
1130
1.07
0.27
7.0
6.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
845
8368
1.06
0.27
4.9
4.8
mmol/l
5.8
6.0
3.61
752
7603
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
22
187
1.18
0.26
1.4
1.2
—
7.3
—
0
14
(46235355) HIV 1 and 2 tests - Meaningful Use set
114
1072
1.07
0.26
1.9
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
104
1.25
0.26
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
67
1.20
0.26
1.4
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
74
0.67
0.26
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
130
1230
1.07
0.26
1.4
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
188
1.17
0.25
1.2
1.3
miu/ml
119.6
231.3
—
7
89
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
234
0.85
0.25
3.0
2.2
ug/min
83.6
111.3
0.23
13
144
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
87
1.27
0.24
1.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
293
1.13
0.24
3.1
1.3
g/l
3.2
3.1
0.25
25
231
(3038026) Centromere Ab [Units/volume] in Serum
10
78
1.28
0.24
1.7
1.1
—
89.0
—
0
5
(3019150) Specific gravity of Urine by Refractometry
178
1857
0.95
0.24
3.9
4.0
kg/l
1.0
1.0
0.27
22
263
(3011397) Hemoglobin [Presence] in Urine by Test strip
199
1913
1.05
0.23
3.5
3.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
115
1.22
0.23
1.9
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
313
1.12
0.23
3.1
1.3
g/l
7.5
7.4
0.12
25
236
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
313
1.12
0.23
3.1
1.3
g/l
3.5
3.9
1.09
24
228
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
313
1.12
0.23
3.1
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
88
1.25
0.22
2.4
2.7
—
463.9
—
0
11
(3024928) Oxygen saturation in Venous blood
20
172
1.17
0.22
4.8
2.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
116
1.21
0.22
1.7
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
2.0
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
13
107
1.22
0.21
1.1
1.3
mmol/l
6.1
7.8
—
8
72
(3022217) INR in Platelet poor plasma by Coagulation assay
119
1131
1.06
0.21
19.0
26.6
inr
1.5
1.3
0.40
12
152
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
2.0
—
0.5
—
0
11
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
14.2
—
0
10
(3044009) aPTT.lupus sensitive (LA screen)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
4.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
228
2356
0.96
0.21
1.6
1.6
mmol/l
1.3
1.4
0.36
195
1973
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.2
—
1.5
—
0
5
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
164
1.16
0.20
1.3
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
111
0.81
0.20
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
115
0.78
0.20
1.1
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
6
52
1.15
0.19
1.3
1.3
mmol/l
4.5
7.2
—
6
46
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
550
1.08
0.19
1.3
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
206
0.87
0.18
1.4
1.9
iu/l
2.7
4.6
—
7
72
(3020682) Albumin/Creatinine [Ratio] in Urine
279
2860
0.97
0.18
3.8
4.0
mg/mmol
16.5
7.9
0.36
162
1785
(40761535) Cells panel - Urine sediment
76
718
1.06
0.17
3.4
3.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
34
310
1.10
0.17
4.4
4.0
mmol/l
1.4
1.4
0.01
34
303
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
67
0.75
0.17
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
167
1.14
0.17
1.2
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
207
2131
0.96
0.17
4.5
4.0
estimate
0.0
0.0
0.69
76
676
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
120
0.83
0.16
1.0
1.1
—
17.0
—
0
8
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
71
1.13
0.16
1.6
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
86
0.81
0.14
1.1
2.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
15
131
1.15
0.14
1.3
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
112
1.16
0.14
1.4
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
39
419
0.93
0.14
3.3
2.8
mmol/l
25.6
25.3
0.25
39
405
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
98
0.81
0.13
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
98
0.81
0.13
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
99
0.81
0.13
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
99
0.81
0.13
1.3
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
530
0.94
0.13
1.2
1.2
iu/ml
142.2
143.3
0.01
19
222
(40760892) CBC W Ordered Manual Differential panel - Blood
170
1745
0.97
0.12
4.7
4.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
52
549
0.94
0.12
1.6
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
280
2849
0.98
0.11
2.9
3.1
mmol/l
7.6
7.4
0.35
235
2403
(36660697) Celiac disease serology panel - Serum
63
659
0.95
0.11
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
209
0.91
0.11
1.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
63
602
1.05
0.11
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
105
1.14
0.11
2.1
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
231
1.08
0.10
1.8
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
44
1.14
0.10
1.6
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(4034850)
32
301
1.07
0.09
6.2
10.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
70
675
1.04
0.09
4.2
3.6
ng/l
91.1
87.1
0.12
60
587
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
60
0.83
0.08
1.6
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
389
0.95
0.08
1.2
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
88
1.14
0.08
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
75
0.80
0.07
1.0
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
77
1.04
0.07
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
235
1.07
0.07
1.1
1.1
—
—
—
0
0
(4062490)
8
78
1.03
0.07
1.1
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
112
0.89
0.07
1.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
82
0.85
0.07
1.3
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
153
0.91
0.07
5.9
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
83
0.84
0.07
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
84
0.83
0.07
1.3
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
85
1.06
0.07
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
87
1.03
0.07
1.7
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
128
1.10
0.06
1.5
1.2
u/ml
198.4
256.1
—
9
73
(3025941) Bacteria identified in Stool by Culture
42
404
1.04
0.06
1.2
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
51
527
0.97
0.06
4.0
2.8
g/l
132.9
130.2
0.43
51
512
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
171
1735
0.98
0.06
1.7
1.7
mg/l
1.3
1.2
0.04
123
1320
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
237
1.06
0.05
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
90
1.11
0.05
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
95
931
1.02
0.05
1.6
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
110
0.91
0.05
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
150
1.07
0.04
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
231
0.95
0.04
1.8
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
181
1791
1.01
0.04
1.3
1.3
u/ml
1.0
1.8
1.04
40
474
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
190
0.95
0.04
1.5
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
65
663
0.98
0.03
1.4
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
240
1.04
0.03
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
161
1.06
0.03
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
35
340
1.03
0.03
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
108
0.93
0.03
1.2
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
91
898
1.01
0.02
2.2
1.7
%
1.4
1.5
0.55
81
766
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
251
2525
0.99
0.02
2.7
2.9
ng/l
1396.4
1275.3
0.15
218
2144
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
146
1473
0.99
0.02
1.4
1.3
iu/ml
57.3
33.9
0.75
43
471
(3023419) Bacteria identified in Sputum by Culture
11
117
0.94
0.01
1.5
2.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
189
1900
0.99
0.01
1.6
1.7
pmol/l
441.2
30122464.6
1.92
149
1557
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
40
393
1.02
0.01
3.3
2.4
%
0.7
0.7
0.62
40
379
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
44
447
0.98
0.01
1.7
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
52
513
1.01
0.01
2.9
2.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
96
1.04
0.00
3.1
2.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
96
1.04
0.00
1.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
108
1.02
0.00
1.3
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
54
544
0.99
0.00
4.0
4.2
%
0.1
0.9
0.43
14
101
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
113
0.97
0.00
1.5
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
137
1.02
0.00
1.4
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
127
1.02
0.00
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
147
1.02
0.00
6.1
3.3
e9/l
4.7
4.3
0.12
15
147
(3044927) Protein electrophoresis panel - Urine
10
99
1.01
0.00
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
109
1.01
0.00
1.1
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
149
1.01
0.00
6.7
3.6
%
56.3
57.7
0.11
15
149
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
38
383
0.99
0.00
4.7
3.4
%
46.2
50.0
0.41
38
378
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
61
613
0.99
0.00
1.7
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
67
667
1.00
0.00
2.1
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
285
0.98
0.00
1.9
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
215
1.02
0.00
1.3
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
90
1.00
0.00
1.3
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(44790049)
7
69
1.01
0.00
1.4
1.7
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
16.3
—
0
6
(3000492) Spirometry study
75
750
1.00
0.00
1.7
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
49
1.02
0.00
1.0
1.4
nmol/l
123.6
156.3
—
5
49
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.5
—
2.2
—
0
6
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
100
1.00
0.00
1.7
1.4
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
11.7
—
0
5
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1.5
—
0
5
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
68
0.88
0.00
9.8
1.7
%
11.3
10.9
—
6
68
(3002032) Base excess in Venous blood by calculation
75
750
1.00
0.00
3.8
3.2
mmol/l
1.9
2.1
0.13
65
600
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790048)
7
69
1.01
0.00
1.4
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
130
1.00
0.00
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(44806118)
7
69
1.01
0.00
1.4
1.7
—
—
—
0
0
(44790047)
7
69
1.01
0.00
1.4
1.7
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
2.8
—
0
6
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
9
92
0.98
0.00
1.7
1.4
—
32.6
—
0
5
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
81
0.99
0.00
4.3
3.8
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
9.7
—
0
6
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CRANIAL_NERVE_EXALLC – Benign neoplasm: Cranial nerves
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).